Given the disruption of the epidermal barrier by AKT1 inhibition, we inferred that in MMD, AKT1 down-regulation might be involved in the pathogenesis by affecting the integrity of the vascular wall. The gene discussed is AKT1; the disease is multiminicore myopathy.